Improving the epilepsy surgery evaluation pipeline: Training and communication
Surgery may be an option for up to 40% of people with drug-resistant epilepsy, but fewer than 1% are referred to epilepsy centers each year. Why?
Stay updated with breaking news from Rushna Ali. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Surgery may be an option for up to 40% of people with drug-resistant epilepsy, but fewer than 1% are referred to epilepsy centers each year. Why?
Surgery may be an option for up to 40% of people with drug-resistant epilepsy, but fewer than 1% are referred to epilepsy centers each year. Why?
AUSTIN, Texas, Feb. 15, 2022 /PRNewswire/ -- The Vivistim clinical trial team won the 2022 Paul Dudley White International Scholar Award for submi...
/PRNewswire/ -- The Vivistim clinical trial team won the 2022 Paul Dudley White International Scholar Award for submitting the highest-ranked abstract from the...
/PRNewswire/ -- The Vivistim clinical trial team won the 2022 Paul Dudley White International Scholar Award for submitting the highest-ranked abstract from the...